Literature DB >> 10072697

Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities.

A Pascale1, R Etcheberrigaray.   

Abstract

Calcium plays a pivotal role in mediating many important biological functions. The intracellular calcium concentration is tightly regulated by a variety of systems and mechanisms. Calcium is sequestered by various organelles such as mitochondria and/or endoplasmic reticulum and extruded across the plasma membrane by energy-dependent transport systems. Different Ca2+-binding proteins are also involved in these processes. Alterations in calcium homeostasis might be critically implicated in brain aging and in the neuropathology of Alzheimer's disease (AD). In fact, one of the postulated mechanisms of beta-amyloid toxicity seems to involve a Ca2+ dysregulation accompanied with enhanced vulnerability to excitotoxic stimuli. Although brain characteristic lesions-plaques and tangles-constitute the hallmarks of AD, accumulated evidence suggests the systemic feature of this disease. Therefore peripheral cell lines may represent a useful approach to explore the cellular pathophysiology of AD, including calcium alterations and associated phenomena. Copyright 1999 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072697     DOI: 10.1006/phrs.1998.0411

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  11 in total

1.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Ameliorative effects of Eriobotrya japonica seed extract on cellular aging in cultured rat fibroblasts.

Authors:  Kazuyo Muramoto; Rong-Dan Quan; Toshiharu Namba; Shojiro Kyotani; Mitsuhiko Miyamura; Yutaka Nishioka; Keiichi Tonosaki; Yoshinori L Doi; Hideto Kaba
Journal:  J Nat Med       Date:  2010-12-25       Impact factor: 2.343

3.  Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis.

Authors:  Miroljub Popović; Maria Caballero-Bleda; Natalija Popović; Luis Puelles; Thomas van Groen; Menno P Witter
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

4.  Antihypertensive medication is associated with less cognitive impairment in the very old with apolipoprotein-E epsilon4 allele.

Authors:  Knut A Hestad; Knut Engedal
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals.

Authors:  A Palotás; J Kálmán; G Laskay; A Juhász; Z Janka; B Penke
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

Review 6.  Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells.

Authors:  R Etcheberrigaray; S Bhagavan
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

Review 7.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 8.  Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Exp Neurol       Date:  2009-04-07       Impact factor: 5.330

9.  Whole blood samples from Alzheimer patients and control donors demonstrate fluorimetric differences.

Authors:  András Palotás; János Kálmán; Miklós Palotás; Keyvan Matin; Károly Szentpáli; Attila Paszt; Zoltán Janka; Botond Penke
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

10.  The Protective Role of Selenium on Scopolamine-Induced Memory Impairment, Oxidative Stress, and Apoptosis in Aged Rats: The Involvement of TRPM2 and TRPV1 Channels.

Authors:  Hasan Balaban; Mustafa Nazıroğlu; Kadir Demirci; İshak Suat Övey
Journal:  Mol Neurobiol       Date:  2016-03-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.